Nicotine Polacrilex Lozenge
Product Images NDC 72162-2266

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nicotine Polacrilex (NDC 72162-2266). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1 (Fig1)

An instructional diagram showing a 4-step timeline for Nicotine Polacrilex lozenge use. Step 1 (week 1) suggests 1 lozenge every 1 to 2 hours. Step 2 (week 7) advises 1 lozenge every 2 to 4 hours. Step 3 (week 10) indicates 1 lozenge every 4 to 8 hours. The final step, labeled EX-SMOKER, occurs 12 weeks after quit date.*

FDA Label Image

Label (Lbl721622266)

Drug Facts panel for Nicotine Polacrilex Lozenge 2 mg includes active ingredient and purpose, uses, warnings, other information, directions, and inactive ingredients. Directions cover dosage schedules and usage instructions. The label shows the NDC 72162-2266-2 and indicates relabeling by Bryant Ranch Prepack, Inc., with packaging of 3 x 24 lozenges.*

FDA Label Image

Pic1 (Pic1)

A wallet card titled 'Where to Call for Help' listing four support contact numbers: American Lung Association, American Cancer Society, American Heart Association, and a quitting buddy or friend who has quit. This card is associated with Nicotine Polacrilex lozenge usage guidance.*

FDA Label Image

Pic2 (Pic2)

A wallet card titled 'My most important reasons to quit smoking are:' with several blank lines for personal entries. The card is likely intended to support smoking cessation efforts alongside Nicotine Polacrilex lozenges.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.